Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

A mycolic acid–specific CD1-restricted T cell population contributes to acute and memory immune responses in human tuberculosis infection
Damien J. Montamat-Sicotte, … , Benjamin E. Willcox, Ajit Lalvani
Damien J. Montamat-Sicotte, … , Benjamin E. Willcox, Ajit Lalvani
Published May 16, 2011
Citation Information: J Clin Invest. 2011;121(6):2493-2503. https://doi.org/10.1172/JCI46216.
View: Text | PDF
Research Article Immunology Article has an altmetric score of 15

A mycolic acid–specific CD1-restricted T cell population contributes to acute and memory immune responses in human tuberculosis infection

  • Text
  • PDF
Abstract

Current tuberculosis (TB) vaccine strategies are largely aimed at activating conventional T cell responses to mycobacterial protein antigens. However, the lipid-rich cell wall of Mycobacterium tuberculosis (M. tuberculosis) is essential for pathogenicity and provides targets for unconventional T cell recognition. Group 1 CD1–restricted T cells recognize mycobacterial lipids, but their function in human TB is unclear and their ability to establish memory is unknown. Here, we characterized T cells specific for mycolic acid (MA), the predominant mycobacterial cell wall lipid and key virulence factor, in patients with active TB infection. MA-specific T cells were predominant in TB patients at diagnosis, but were absent in uninfected bacillus Calmette-Guérin–vaccinated (BCG-vaccinated) controls. These T cells were CD1b restricted, detectable in blood and disease sites, produced both IFN-γ and IL-2, and exhibited effector and central memory phenotypes. MA-specific responses contracted markedly with declining pathogen burden and, in patients followed longitudinally, exhibited recall expansion upon antigen reencounter in vitro long after successful treatment, indicative of lipid-specific immunological memory. T cell recognition of MA is therefore a significant component of the acute adaptive and memory immune response in TB, suggesting that mycobacterial lipids may be promising targets for improved TB vaccines.

Authors

Damien J. Montamat-Sicotte, Kerry A. Millington, Carrie R. Willcox, Suzie Hingley-Wilson, Sarah Hackforth, John Innes, Onn Min Kon, David A. Lammas, David E. Minnikin, Gurdyal S. Besra, Benjamin E. Willcox, Ajit Lalvani

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2009 Total
Citations: 2 2 5 2 3 4 4 7 4 5 8 6 1 2 1 1 57
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (57)

Title and authors Publication Year
Lipid Antigens: Revealing the Hidden Players in Adaptive Immune Responses
Eskandari T, Eivazzadeh Y, Khaleghinia F, Kashi F, Oksenych V, Haghmorad D
Biomolecules 2025
Sensing mycobacteria through unconventional pathways
Almeida CF, Juno JA
The Journal of Clinical Investigation 2025
Trained Immunity Generated by the Recombinant Zoster Vaccine
Weinberg A, Johnson M, Crotteau M, Ghosh D, Vu T, Levin MJ
Research square 2024
Establishment of CD1b-restricted immunity to lipid antigens in the pulmonary response to Mycobacterium tuberculosis infection
Harris MC, Gary HE, Cooper SK, Ackart DF, DiLisio JE, Basaraba RJ, Cheng TY, van Rhijn I, Branch Moody D, Podell BK
Infection and Immunity 2024
Comparative immune responses to M. tuberculosis in individuals with latent infection or sterile protection against infection
Emilie Jalbert, Cuining Liu, Vidya Mave, Nancy Lang, Anju Kagal, Chhaya Valvi, Mandar Paradkar, Nikhil Gupte, Rahul Lokhande, Renu Bharadwaj, Vandana Kulkarni, Amita Gupta, Adriana Weinberg
iScience 2023
Impact of SIV infection on mycobacterial lipid-reactive T cell responses in Bacillus Calmette-Guérin (BCG) inoculated macaques
Walker EM, Merino KM, Slisarenko N, Grasperge BF, Mehra S, Roy CJ, Kaushal D, Rout N
Frontiers in immunology 2023
Vaccination with mycobacterial lipid loaded nanoparticle leads to lipid antigen persistence and memory differentiation of antigen-specific T cells
Morgun E, Zhu J, Almunif S, Bobbala S, Aguilar MS, Wang J, Conner K, Cui Y, Cao L, Seshadri C, Scott EA, Wang CR
eLife 2023
Vaccination with mycobacterial lipid loaded nanoparticle leads to lipid antigen persistence and memory differentiation of antigen-specific T cells
Morgun E, Zhu J, Almunif S, Bobbala S, Aguilar MS, Wang J, Conner K, Cui Y, Cao L, Seshadri C, Scott EA, Wang CR
2023
Innate and Adaptive Cell-Mediated Immune Responses to a COVID-19 mRNA Vaccine in Young Children
Weinberg A, Johnson MJ, Garth K, Hsieh EW, Kedl R, Weiskopf D, Cassaday M, Rester C, Cabrera-Martinez B, Baxter RM, Levin MJ
Open Forum Infectious Diseases 2023
Recent Developments in Drug Delivery for Treatment of Tuberculosis by Targeting Macrophages
Gairola A, Benjamin A, Weatherston JD, Cirillo JD, Wu HJ
2022
Immunological hyporesponsiveness in tuberculosis: The role of mycobacterial glycolipids
Correia-Neves M, Nigou J, Mousavian Z, Sundling C, Källenius G
Frontiers in immunology 2022
The role of donor‐unrestricted T‐cells, innate lymphoid cells, and NK cells in anti‐mycobacterial immunity
P Ruibal, L Voogd, SA Joosten, TH Ottenhoff
Immunological Reviews 2021
New Developments and Insights in the Improvement of Mycobacterium tuberculosis Vaccines and Diagnostics Within the End TB Strategy
JI García, A Allué-Guardia, RP Tampi, BI Restrepo, JB Torrelles
Current Epidemiology Reports 2021
Role of Group 1 CD1-restricted T Cells in Host Defense and Inflammatory Diseases
Morgun E, Cao L, Wang CR
Critical reviews in immunology 2021
CD1b Tetramers Broadly Detect T Cells That Correlate With Mycobacterial Exposure but Not Tuberculosis Disease State
K Lopez, SK Iwany, S Suliman, JF Reijneveld, TA Ocampo, J Jimenez, R Calderon, L Lecca, MB Murray, DB Moody, IV Rhijn
Frontiers in immunology 2020
T Cell Immunity to Bacterial Pathogens: Mechanisms of Immune Control and Bacterial Evasion
FR Shepherd, JE McLaren
International journal of molecular sciences 2020
Distinct Human NK Cell Phenotypes and Functional Responses to Mycobacterium tuberculosis in Adults From TB Endemic and Non-endemic Regions
LD Harris, J Khayumbi, J Ongalo, LE Sasser, J Tonui, A Campbell, FH Odhiambo, SG Ouma, G Alter, NR Gandhi, CL Day
Frontiers in Cellular and Infection Microbiology 2020
Group 1 CD1-restricted T cells contribute to control of systemic Staphylococcus aureus infection
L Visvabharathy, S Genardi, L Cao, Y He, F Alonzo, E Berdyshev, CR Wang, DM Lewinsohn
PLoS pathogens 2020
Differential skewing of donor-unrestricted and γδ T-cell repertoires in tuberculosis-infected human lungs
Paul Ogongo, Adrie JC Steyn, Farina Karim, Kaylesh Dullabh, Ismael Awala, Rajhmun Madansein, Alasdair Leslie, Samuel M. Behar
Journal of Clinical Investigation 2019
Immunology of Mycobacterium tuberculosis Infections
JK Sia, J Rengarajan
Microbiology spectrum 2019
Diet in the Driving Seat: Natural Diet-Immunity-Microbiome Interactions in Wild Fish
IM Friberg, JD Taylor, JA Jackson
Frontiers in immunology 2019
Harnessing donor unrestricted T-cells for new vaccines against tuberculosis
SA Joosten, TH Ottenhoff, DM Lewinsohn, DF Hoft, DB Moody, C Seshadri
Vaccine 2019
CD1-Restricted T Cells During Persistent Virus Infections: “Sympathy for the Devil”
G Schönrich, MJ Raftery
Frontiers in immunology 2018
The Conventional Nature of Non-MHC-Restricted T Cells
M Lepore, L Mori, GD Libero
Frontiers in immunology 2018
Validation of a CD1b tetramer assay for studies of human mycobacterial infection or vaccination
ED Layton, KK Yu, MT Smith, TJ Scriba, SC Rosa, C Seshadri
Journal of Immunological Methods 2018
Early clearance versus control: what is the meaning of a negative tuberculin skin test or interferon-gamma release assay following exposure to Mycobacterium tuberculosis?
EW Meermeier, DM Lewinsohn
F1000Research 2018
The versatility of the CD1 lipid antigen presentation pathway
A Chancellor, SD Gadola, S Mansour
Immunology 2018
Research and development of new tuberculosis vaccines: a review
LK Schrager, RC Harris, J Vekemans
F1000Research 2018
Induction of Mycobacterium Tuberculosis Lipid-Specific T Cell Responses by Pulmonary Delivery of Mycolic Acid-Loaded Polymeric Micellar Nanocarriers
S Shang, D Kats, L Cao, E Morgun, D Velluto, Y He, Q Xu, CR Wang, EA Scott
Frontiers in immunology 2018
MHC Ib molecule Qa-1 presents Mycobacterium tuberculosis peptide antigens to CD8+ T cells and contributes to protection against infection
Y Bian, S Shang, S Siddiqui, J Zhao, SA Joosten, TH Ottenhoff, H Cantor, CR Wang, DM Lewinsohn
PLoS pathogens 2017
CD1b-mycolic acid tetramers demonstrate T-cell fine specificity for mycobacterial lipid tails
IV Rhijn, SK Iwany, P Fodran, TY Cheng, L Gapin, AJ Minnaard, DB Moody
European Journal of Immunology 2017
How T cells grasp mycobacterial lipid antigens
DB Moody
Proceedings of the National Academy of Sciences 2017
CD1b-restricted GEM T cell responses are modulated by Mycobacterium tuberculosis mycolic acid meromycolate chains
A Chancellor, AS Tocheva, C Cave-Ayland, L Tezera, A White, JR Dulayymi, JS Bridgeman, I Tews, S Wilson, NM Lissin, M Tebruegge, B Marshall, S Sharpe, T Elliott, CK Skylaris, JW Essex, MS Baird, S Gadola, P Elkington, S Mansour
Proceedings of the National Academy of Sciences 2017
Lipoarabinomannan-Responsive Polycytotoxic T Cells Are Associated with Protection in Human Tuberculosis
M Busch, C Herzmann, S Kallert, A Zimmermann, C Höfer, D Mayer, SF Zenk, R Muche, C Lange, BR Bloom, RL Modlin, S Stenger
American journal of respiratory and critical care medicine 2016
Unconventional Human T Cells Accumulate at the Site of Infection in Response to Microbial Ligands and Induce Local Tissue Remodeling
AR Liuzzi, A Kift-Morgan, M Lopez-Anton, IM Friberg, J Zhang, AC Brook, GW Roberts, KL Donovan, CS Colmont, MA Toleman, T Bowen, DW Johnson, N Topley, B Moser, DJ Fraser, M Eberl
Journal of immunology (Baltimore, Md. : 1950) 2016
Mechanisms and Consequences of Antigen Presentation by CD1
LV Kaer, L Wu, S Joyce
Trends in Immunology 2016
Immunotherapy for tuberculosis: future prospects
D Hoft, G Abate
ImmunoTargets and Therapy 2016
Nonclassical MHC Ib-restricted CD8+ T Cells Recognize Mycobacterium tuberculosis-Derived Protein Antigens and Contribute to Protection Against Infection
S Shang, S Siddiqui, Y Bian, J Zhao, CR Wang, DM Lewinsohn
PLoS pathogens 2016
Role of Group 1 CD1-Restricted T Cells in Infectious Disease
S Siddiqui, L Visvabharathy, CR Wang
Frontiers in immunology 2015
CD8 T cells and Mycobacterium tuberculosis infection
PL Lin, JA Flynn
Seminars in Immunopathology 2015
Adoptive T Cell Therapy Targeting CD1 and MR1
T Guo, K Chamoto, N Hirano
Frontiers in immunology 2015
Tuberculosis vaccines: barriers and prospects on the quest for a transformative tool
CL Karp, CB Wilson, LM Stuart
Immunological Reviews 2015
Early innate responses to pathogens: pattern recognition by unconventional human T-cells
AR Liuzzi, JE McLaren, DA Price, M Eberl
Current Opinion in Immunology 2015
HIV Disrupts Human T Cells That Target Mycobacterial Glycolipids
VO Kasprowicz, TY Cheng, T Ndung'u, H Sunpath, DB Moody, AG Kasmar
The Journal of Infectious Diseases 2015
Mycolic acid-specific T cells protect against Mycobacterium tuberculosis infection in a humanized transgenic mouse model: ( A ) Schematic diagram of DN1 TCR construct used to generate DN1Tg mice. ( B ) The presence of DN1 TCR in the genomic DNA of transgenic mice was examined by PCR using primers specific for TRAV13-2 and TRAJ57. DN1 plasmid was used as a positive control (Ctrl). ( C ) DN1 T cells in the spleen of DN1Tg + and DN1Tg - mice (in a B6 background) were detected by FACS using anti-mouse TCRβ and anti-human Vβ5.1 mAbs. ( D ) Lymphocytes from the thymus, spleen and liver of DN1Tg/hCD1Tg and DN1Tg mice (in the Rag-deficient background) were analyzed for the presence of DN1 T cells (TCRβ + hVβ5.1 + ). ( E, F ) Bar graphs depict the mean and SEM of the percentages (in the lymphocyte gate) and absolute numbers of DN1 T cells from DN1Tg/hCD1Tg and DN1Tg mice (n=3–8 per group). *** pppG) Expression of indicated markers (black line) on DN1 T cells (TCRβ + hVβ5.1 + ) from DN1Tg/hCD1Tg/Rag -/- mice, type I NKT cells (CD1d/αGalCer tetramer + TCRβ + ) from WT mice, and conventional CD8 + T cells (TCRβ + CD8 + ) from WT mice, compared with isotype control (gray filled). The expression of CD4 and CD8 on DN1 T cells and type I NKT cells were shown in the dot plots. Cells isolated from the thymus were used for PLZF staining. Results are representative of 3 experiments
J Zhao, S Siddiqui, S Shang, Y Bian, S Bagchi, Y He, CR Wang
eLife 2015
T Cell Responses against Mycobacterial Lipids and Proteins Are Poorly Correlated in South African Adolescents
C Seshadri, L Lin, TJ Scriba, G Peterson, D Freidrich, N Frahm, SC DeRosa, DB Moody, J Prandi, M Gilleron, H Mahomed, W Jiang, G Finak, WA Hanekom, R Gottardo, MJ McElrath, TR Hawn
Journal of immunology (Baltimore, Md. : 1950) 2015
The T-Cell Response to Lipid Antigens of Mycobacterium tuberculosis
GD Libero, L Mori
Frontiers in immunology 2014
A polymorphism in human CD1A is associated with susceptibility to tuberculosis
C Seshadri, NT Thuong, NT Yen, ND Bang, TT Chau, GE Thwaites, SJ Dunstan, TR Hawn
Genes and Immunity 2014
A novel self-lipid antigen targets human T cells against CD1c(+) leukemias
M Lepore, C Lalla, SR Gundimeda, H Gsellinger, M Consonni, C Garavaglia, S Sansano, F Piccolo, A Scelfo, D Häussinger, D Montagna, F Locatelli, C Bonini, A Bondanza, A Forcina, Z Li, G Ni, F Ciceri, P Jenö, C Xia, L Mori, P Dellabona, G Casorati, GD Libero
Journal of Experimental Medicine 2014
Protective Effect of a Lipid-Based Preparation from Mycobacterium smegmatis in a Murine Model of Progressive Pulmonary Tuberculosis
MA los García, R Borrero, ME Lanio, Y Tirado, N Alvarez, A Puig, A Aguilar, L Canet, DM Espinoza, JB Payán, ME Sarmiento, R Hernández-Pando, MN Norazmi, A Acosta
BioMed Research International 2014
Targeted Delivery of Mycobacterial Antigens to Human Dendritic Cells via Siglec-7 Induces Robust T Cell Activation
N Kawasaki, CD Rillahan, TY Cheng, IV Rhijn, MS Macauley, DB Moody, JC Paulson
Journal of immunology (Baltimore, Md. : 1950) 2014
Nonclassical T Cells and Their Antigens in Tuberculosis
GD Libero, A Singhal, M Lepore, L Mori
Cold Spring Harbor Perspectives in Medicine 2014
A conserved human T cell population targets mycobacterial antigens presented by CD1b
IV Rhijn, A Kasmar, A Jong, S Gras, M Bhati, ME Doorenspleet, N Vries, DI Godfrey, JD Altman, W Jager, J Rossjohn, DB Moody
Nature Immunology 2013
The immunological life cycle of tuberculosis
JD Ernst
Nature Reviews Immunology 2012
Protection versus pathology in tuberculosis: recent insights
AM Cooper, E Torrado
Current Opinion in Immunology 2012
CD1b tetramers bind αβ T cell receptors to identify a mycobacterial glycolipid-reactive T cell repertoire in humans
AG Kasmar, I Rhijn, TY Cheng, M Turner, C Seshadri, A Schiefner, RC Kalathur, JW Annand, A Jong, J Shires, L Leon, M Brenner, IA Wilson, JD Altman, DB Moody
Journal of Experimental Medicine 2011
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Blogged by 1
Referenced in 4 patents
136 readers on Mendeley
1 readers on CiteULike
See more details